Investment Analysts’ Updated EPS Estimates for September 10th (AAPL, AVAV, AVO, BBIO, BCRX, BLZE, BMRN, BOW, BWAY, CAT)

Investment Analysts’ updated eps estimates for Thursday, September 10th:

Apple (NASDAQ:AAPL) had its neutral rating reiterated by analysts at Rosenblatt Securities. They currently have a $303.00 target price on the stock.

Apple (NASDAQ:AAPL) had its buy rating reissued by analysts at TD Cowen. TD Cowen currently has a $400.00 target price on the stock.

AeroVironment (NASDAQ:AVAV) had its market outperform rating reaffirmed by analysts at Citizens Jmp. They currently have a $230.00 price target on the stock.

AeroVironment (NASDAQ:AVAV) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $225.00 price target on the stock.

AeroVironment (NASDAQ:AVAV) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $205.00 target price on the stock.

Mission Produce (NASDAQ:AVO) had its buy rating reissued by analysts at Roth Capital. They currently have a $17.00 target price on the stock.

BridgeBio Pharma (NASDAQ:BBIO) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $120.00 price target on the stock.

BioCryst Pharmaceuticals (NASDAQ:BCRX) was downgraded by analysts at Royal Bank Of Canada from an outperform rating to a sector perform rating. Royal Bank Of Canada currently has $11.00 target price on the stock, down from their previous target price of $13.00.

Backblaze (NASDAQ:BLZE) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $23.00 target price on the stock.

BioMarin Pharmaceutical (NASDAQ:BMRN) had its neutral rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $60.00 price target on the stock.

Bowhead Specialty (NYSE:BOW) had its market perform rating reaffirmed by analysts at Citizens Jmp.

Brainsway (NASDAQ:BWAY) had its buy rating reissued by analysts at BTIG Research. They currently have a $20.00 target price on the stock.

Caterpillar (NYSE:CAT) was upgraded by analysts at Freedom Broker from a hold rating to a buy rating. The firm currently has $980.00 target price on the stock.

Crescent Capital BDC (NASDAQ:CCAP) had its neutral rating reiterated by analysts at Bank of America Corporation. Bank of America Corporation currently has a $10.25 price target on the stock, down from their previous price target of $13.00.

Chewy (NYSE:CHWY) had its hold rating reiterated by analysts at Needham & Company LLC.

Chewy (NYSE:CHWY) had its market outperform rating reiterated by analysts at Citizens Jmp. Citizens Jmp currently has a $28.00 price target on the stock.

Cipher Mining (NASDAQ:CIFR) had its buy rating reissued by analysts at Rosenblatt Securities. The firm currently has a $30.00 price target on the stock.

Cooper Companies (NASDAQ:COO) had its market perform rating reiterated by analysts at William Blair.

Cooper Companies (NASDAQ:COO) had its neutral rating reissued by analysts at Bank of America Corporation. Bank of America Corporation currently has a $65.00 price target on the stock, down from their previous price target of $80.00.

Centerspace (NYSE:CSR) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $57.00 target price on the stock.

Currys (LON:CURY) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 210 price target on the stock.

Debenhams Capital (LON:DEBS) had its buy rating reissued by analysts at Shore Capital Group Ltd. Shore Capital Group Ltd currently has a GBX 35 price target on the stock.

DNOW (NYSE:DNOW) had its hold rating reissued by analysts at Freedom Broker. Freedom Broker currently has a $18.00 target price on the stock.

8X8 (NASDAQ:EGHT) had its buy rating reiterated by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $3.00 price target on the stock.

EVI Industries (NYSEAMERICAN:EVI) had its buy rating reissued by analysts at DA Davidson. They currently have a $32.00 price target on the stock.

Gencor Industries (NASDAQ:GENC) had its hold rating reaffirmed by analysts at Freedom Broker. Freedom Broker currently has a $21.00 target price on the stock, up from their previous target price of $19.00.

Gloo (NASDAQ:GLOO) had its market outperform rating reaffirmed by analysts at Citizens Jmp. They currently have a $8.00 price target on the stock.

Genus (LON:GNS) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 3,350 price target on the stock.

GRI Bio (NASDAQ:GRI) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $10.00 target price on the stock.

Herc (NYSE:HRI) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. JPMorgan Chase & Co. currently has $175.00 price target on the stock, up from their previous price target of $165.00.

Immunome (NASDAQ:IMNM) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $40.00 target price on the stock.

Immunic (NASDAQ:IMUX) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $22.00 price target on the stock.

Immunic (NASDAQ:IMUX) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $45.00 target price on the stock.

Disc Medicine (NASDAQ:IRON) had its outperform rating reissued by analysts at Wedbush. The firm currently has a $100.00 price target on the stock.

Independence Realty Trust (NYSE:IRT) had its market outperform rating reiterated by analysts at Citizens Jmp. Citizens Jmp currently has a $22.00 target price on the stock.

Jersey Mike’s (NYSE:JMKE) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $28.00 price target on the stock.

KB Home (NYSE:KBH) had its market outperform rating reissued by analysts at Citizens Jmp. They currently have a $77.00 target price on the stock.

Novogen (NASDAQ:KZIA) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $40.00 price target on the stock.

McBride (LON:MCB) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 275 price target on the stock.

Meta Platforms (NASDAQ:META) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. They currently have $820.00 target price on the stock, up from their previous target price of $640.00.

Navan (NASDAQ:NAVN) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $30.00 price target on the stock.

Navan (NASDAQ:NAVN) had its market outperform rating reissued by analysts at Citizens Jmp. The firm currently has a $38.00 price target on the stock.

Netcall (LON:NET) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 160 price target on the stock.

SailPoint (NASDAQ:SAIL) had its neutral rating reaffirmed by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $17.00 target price on the stock.

SailPoint (NASDAQ:SAIL) had its neutral rating reissued by analysts at DA Davidson. They currently have a $17.00 target price on the stock.

Serina Therapeutics (NYSEAMERICAN:SER) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $8.00 price target on the stock.

Seaport Therapeutics (NASDAQ:SPTX) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $50.00 target price on the stock.

Tyra Biosciences (NASDAQ:TYRA) had its outperform rating reissued by analysts at Wedbush. The firm currently has a $53.00 target price on the stock.

United Rentals (NYSE:URI) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $1,170.00 price target on the stock, down from their previous price target of $1,235.00.

Walmart (NASDAQ:WMT) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $140.00 price target on the stock.

Walmart (NASDAQ:WMT) had its buy rating reaffirmed by analysts at DA Davidson. The firm currently has a $132.00 price target on the stock.